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Abstract 19 
Each heartbeat is initiated by cyclic spontaneous depolarization of cardiomyocytes in the sinus node forming the 20 
primary natural pacemaker. In patients with end-stage renal disease undergoing hemodialysis, it was lately 21 
shown that the heart rate drops to very low values b fore they suffer from sudden cardiac death with an 22 
unexplained high incidence. We hypothesize that the electrolyte changes commonly occurring in these patients 23 
affect sinus node beating rate and could be responsible for severe bradycardia. To test this hypothesis, we 24 
extended the Fabbri et al. computational model of human sinus node cells to account for the dynamic 25 
intracellular balance of ion concentrations. Using this model, we systematically tested the effect of altered 26 
extracellular potassium, calcium, and sodium concentrations. While sodium changes had negligible 27 
(0.15bpm/mM) and potassium changes mild effects (8bpm/mM), calcium changes markedly affected the beating 28 
rate (46bpm/mM ionized calcium without autonomic contr l). This pronounced bradycardic effect of 29 
hypocalcemia was mediated primarily by ICaL attenuation due to reduced driving force particularly during late 30 
depolarization. This in turn caused secondary reduction of calcium concentration in the intracellular 31 
compartments and subsequent attenuation of inward INaCa and reduction of intracellular sodium. Our in silico 32 
findings are complemented and substantiated by an empirical database study comprising 22,501 pairs of bl od 33 
samples and in vivo heart rate measurements in hemodialysis patients and healthy individuals. A reduction of 34 
extracellular calcium was correlated with a decrease of heartrate by 9.9bpm/mM total serum calcium (p<0.001) 35 
with intact autonomic control in the cross-sectional population. In conclusion, we present mechanistic in silico 36 
and empirical in vivo data supporting the so far neglected but experimentally testable and potentially important 37 
mechanism of hypocalcaemia-induced bradycardia and asystole, potentially responsible for the highly increased 38 
and so far unexplained risk of sudden cardiac death in t e hemodialysis patient population. 39 
Statement of Significance 40 
We propose a pathomechanism potentially responsible for the >10,000 yearly sudden cardiac deaths in 41 
hemodialysis patients. Using a computational model of human sinus node cells, we show how a reduction of 42 
extracellular calcium causes severe slowing of spontaneous sinus node beating by attenuation of ICaL, particularly 43 
during late diastolic depolarization. Secondary reduction of calcium in the intracellular compartments and 44 
subsequent attenuation of inward INaCa and reduction of intracellular sodium occurs. These findings are 45 
substantiated by an in vivo analysis of >22,000 blood samples showing a highly significant bradycardic effect of 46 
hypocalcaemia. In conclusion, we present mechanistic n silico and empirical in vivo data supporting the 47 
experimentally testable hypothesis of hypocalcaemia-induced bradycardia, potentially responsible for sudden 48 
cardiac death in hemodialysis patients.  49 
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Introduction 50 
The heart is driven by regular excitations generated in the sinus node as the natural pacemaker. The spontaneous 51 
beating of sinus node myocytes and its rate is governed by a delicate balance of inward and outward 52 
transmembrane currents in the diastolic depolarization (DD) phase of the action potential (AP) and the intricate 53 
interplay of the calcium and membrane clocks, known as the coupled clock mechanism (1, 2). A key factor 54 
affecting sinus node cellular electrophysiology is the extracellular milieu, which is tightly controlled in 55 
mammals. Among others, the kidneys play a crucial role in maintaining homeostasis and keeping electrolyte 56 
concentrations in the blood and the extracellular milieu within narrow ranges. In end-stage renal disease (ESRD) 57 
patients undergoing hemodialysis (HD) however, the renal system fails to maintain electrolyte homeostasi  with 58 
consequences for several other organ systems includg the heart and its electrical conduction system with the 59 
sinus node as the intrinsic natural pacemaker. The ESRD population is large with >700,000 patients in Europe 60 
alone (3). 61 
A particularly severe complication is sudden cardiac death (SCD), which is abnormally frequent in the HD62 
population. Indeed, the SCD-related mortality is increased 14-fold in ESRD patients undergoing HD when 63 
compared to subjects with a history of cardiovascular disease and normal kidney function (4). Traditional 64 
cardiovascular risk factors do not explain the exceptionally high rate of SCD in HD patients (4, 5). While the 65 
most common pathomechanisms underlying SCD in the general population are tachyarrhythmias (ventricular 66 
tachycardia, ventricular fibrillation), several independent studies recently indicated that bradycardia and asystole 67 
are likely to be the dominant pathomechanisms of SCD in ESRD patients. Wong et al. implanted cardiac 68 
monitors in 50 HD patients (6). The monitors could be interrogated in 6 patients who died from SCD in the 18±4 69 
months follow-up period. All these patients died from severe bradycardia followed by asystole and none of them 70 
showed ventricular tachyarrhythmia before or after bradycardic events (6). All SCDs occurred in the long 71 
interdialytic period suggesting a major role for accumulation or depletion of certain substances betwen dialysis 72 
sessions affecting the electrical pacemaking and couction system of the heart as a key pathomechanism. Up to 73 
date, the actual pathomechanism behind the unexplained high rate of SCD in HD patients remains elusive (4, 7) 74 
and very recently, unconventional ideas like plastic chemical exposure were put forward (8). Interestingly, the 75 
findings by Wong et al. were confirmed and complemented by other studies collectively comprising 317 dialysis 76 
patients as recently reviewed (7, 9). These in vivo data indicate that bradycardia and asystole are mor  frequent 77 
than ventricular fibrillation as a cause of SCD in ESRD patients and led us to hypothesize that there is a role of 78 
the cardiac pacemaking system and that spontaneous sin s node beating rate in humans is modulated to a degree 79 
that could cause severe bradycardia by electrolyte concentration changes in the extracellular space as frequently 80 
occurring in ESRD patients on HD.  81 
In this study, we test this hypothesis in a computation l model based on the Fabbri et al. model of human sinus 82 
node cells (10). A computational approach provides controlled conditions and allows to investigate therole of 83 
electrolyte changes on cellular sinus node pacemaking in a human setting. This is challenging experimentally as 84 
human sinus node cells are very rarely available. Given the vastly different beating rates of commonly used 85 
laboratory animals (mouse: 500bpm, rabbit: 300bpm) and humans (60bpm), it cannot be assumed that the 86 
delicate balance of competing effects on pacemaking can be transferred from animal models to humans in 87 
general and in particular during late DD, which only exists at comparatively low beating rates as typical for 88 
humans. Indeed, a computational inter-species analysis revealed fundamental differences regarding the response 89 
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to extracellular ion concentration changes between human and animal (rabbit, mouse) models with a markedly 90 
higher effect in humans (11). 91 
Our computational study yields mechanistic insight and an experimentally testable hypothesis regarding the 92 
regulation of sinus node pacemaker cell function suggesting a pathomechanism that could be responsible for a 93 
large number of sudden bradycardic deaths in ESRD patients. To complement and substantiate our in silico 94 
findings, we analyze the statistical in vivo relation between heart rate and blood electrolyte concentration in 95 
large HD and cross-sectional populations.  96 
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Materials and Methods 97 
Model Development and Validation 98 
The intracellular ion concentrations depend on the extracellular milieu, which is tightly controlled under 99 
physiological conditions. Therefore, it is common to consider constant [K+] i and [Na
+] i in cyclic steady-state 100 
simulations, as proposed in the original Fabbri et al. model (10). However, when modeling the effects of altered 101 
extracellular concentrations as occurring in ESRD patients, this assumption is not valid anymore as intracellular 102 
concentrations will respond to changes of the extracellular milieu. Therefore, we extended the original model as 103 
described in detail in (11). In brief, we considered the dynamic balance of intracellular K+ and Na+ 104 
concentrations as governed by their influx and efflux. Additionally, we added a small conductance calcium-105 
activated potassium current (ISK) as proposed in (12, 13). Lastly, the formulation f the maximum IKr 106 
conductivity gKr was adapted to take the dependency on [K
+]o into account as described for other 107 
cardiomyocytes (14): 108 
 109 
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 110 
A schematic of the updated model is shown in Figure 1. All parameters and initial values of the update model 111 
are available in (11) together with the unaltered equations of the original model as detailed in (10). AP features 112 
of the updated model (11) were closer to experimental values than those of the original model except for APD, 113 
AP overshoot, and the diastolic depolarization rate during the first 100ms (DDR100), which is higher in the 114 
updated model leading to a more pronounced biphasic DD. The resulting model was validated against the same 115 
experimental data as the original model (10). The effect of If, INa, and IKs mutations was not markedly affected by 116 
the changes to the model. The response to complete I f block (cycle length +25.9%) was in accordance with the 117 
available experimental human data (+26% (15)). In summary, the updated model exhibits homeostasis of 118 
intracellular ion concentrations across time spans of minutes and thereby puts further physiological constraints 119 
on the free parameters compared to the original version without impairing reproduction of experimental AP and 120 
CaT features.  121 
 122 
Figure 1: Schematic diagram of the updated human SAN cell model. Compared to the original Fabbri et al. model (10), a 123 
small conductance calcium-activated potassium current (ISK) was added and the model took into account the dependency of 124 
gKr  on [K
+]o as well as the dynamic intracellular concentration changes of not only calcium but also sodium and potassium. 125 
Details regarding the updated model including the full list of parameters and initial values can be found in (11). 126 
Simulation Study 127 
Based on a pilot study (16), we performed a simulation study varying the extracellular electrolyte cone trations 128 
in ranges also including the interval observed in HD patients. [Na+]o was varied between 120 and 160mM, [K
+]o 129 
between 3 and 9mM, and [Ca2+]o between 0.8 and 2.9mM. The single cell model was numerically integrated with 130 
MATLAB’s (The MathWorks Inc., Natick, MA, USA) variable order stiff ordinary differential equation solver 131 
ode15s. Absolute and relative tolerances were set to 1e-6and the maximum allowed time step for the solver was 132 
1ms. Each setup was run for 100s after which a cyclic steady state was reached (cycle length standard deviation 133 
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for the last 5 beats < 0.1%). To disentangle the contribution of the 3 currents directly affected by changes of 134 
[Ca2+]o, namely ICaL, ICaT, and INaCa, we performed additional simulation in which just one of the currents was 135 
exposed to the altered [Ca2+]o whereas the other two were computed using the referenc  concentration of 1.8mM. 136 
We evaluated the following AP and CaT features for each of the simulated scenarios: cycle length, AP duration 137 
at 90% repolarization (APD90), maximum diastolic potential (MDP), AP overshoot, DDR100 as a first order 138 
approximation of the DD rate during the first 100ms, aximum AP upstroke velocity dV/dtmax, ttakeoff and Vtakeoff 139 
at AP takeoff identified as the first time step after tMDP + 100ms for which #$ #%$&  > 1000mV/s2, CaT duration 140 
at 50% (CaTD50), and CaT amplitude. To study the contribution of individual currents in the different temporal 141 
phases of DD, we split this phase into early DD (first 100ms after tMDP) and late DD (the remainder). Moreover, 142 
we linearly extrapolated the effect of the first 100ms of DD onto the whole DD phase: 143 
%'(),+,, =	-)./00 −12113+,, 	, 
and defined tdia,late as the remaining DD not captured by this first order approximation based on the first 100ms: 144 %'(),4)-/ = %-)./00 − %'(),+,,	. 
Retrospective Analysis of Clinical Data 145 
To identify the in vivo relationship between heart ra e and blood electrolyte concentrations, two large HD and 146 
cross-sectional populations were used. Our analysis included 741 HD patients over 4391 observations receiving 147 
chronic maintenance HD treatment for at least 3 months but not longer than one year. Patients that had 4 or more 148 
calcium and potassium measurement accompanied with an assessment of predialysis heart rate were included in 149 
the analysis. The longitudinal association was quantified using a linear mixed effects model with the additional 150 
random effect of considering the time from the first dialysis. The Western IRB determined this study in HD 151 
patients as exempt and in compliance with the Health Insurance Portability and Accountability Act of 1996 152 
(HIPAA). As an independent second population, 18,141 individuals were assessed from the 2011-2016 Nation l 153 
Health and Nutrition Examination Survey (NHANES) US cross-sectional database (15). Appropriate sample 154 
weights were used to ensure the results are representativ  for the US population as a whole. In comparison to the 155 
HD patients, the NHANES study did not contain a longitudinal aspect. Therefore, a linear regression model was 156 
used. Additionally, both datasets were split into three age categories: younger than 50 years, between 50 a d 69 157 
years and 70 years or older and analysis was done per sex. Statistical significance was assessed by Studen ’s t-158 
test after checking for normal distributions. All results are given as mean ± standard deviation.  159 
 Page 7 of 16 
Results 160 
Hypocalcaemia Severely Slows Pacemaking in silico 161 
 162 
Figure 2: Action potential (A) and calcium transient (B) of the reference model (blue), as well as hypokalemic (red) and 163 
hypocalcaemic (yellow) setups. 164 
 165 
Figure 3: Action potential (AP) and calcium transient (CaT) feature dependency on extracellular calcium concentration 166 
[Ca2+]o. (A) cycle length of spontaneous sinus node cell beating, (B) AP duration at 90% repolarization, (C) maximum 167 
diastolic potential, (D) AP overshoot, (E) diastolic depolarization rate during the first 100ms after MDP, (F) AP upstroke 168 
velocity, (G) CaT duration at 50%, (H) CaT amplitude. The thick blue line represents the scenario in which all currents were 169 
exposed to the altered [Ca2+]o, whereas the thin lines represent scenarios in which only one current was exposed to the 170 
altered concentration while the other two were computed with 1.8mM. 171 
The spontaneous beating cycle length of the human sinus node cell model as well as AP and CaT morphology 172 
changed when varying extracellular calcium and potassium concentrations ( 173 
Figure 2). The cycle length showed a pronounced inverse relation with the extracellular calcium concentration 174 
[Ca2+]o. The super-linear course, particularly for low [Ca
2+]o, led to cycle lengths up to 2300ms at 0.8mM, i.e.,175 
beating rates down to 26bpm (Figure 3A). APD90 was shortened by both hyper- and hypocalcaemia, however by 176 
less than 8ms (Figure 3B) similar to AP overshoot (Figure 3D) and dV/dtmax (Figure 3F). MDP showed a 177 
monotonic relation with a maximum reduction of 1.2mV at 0.8mM [Ca2+]o (Figure 3C) similar to DDR100, which 178 
was slowed by a maximum of 20mV/s at 0.8mM compared to 1.8mM [Ca2+]o (Figure 3E). CaTD was longer and 179 
CaT amplitude smaller for lower [Ca2+]o (Figure 3F+G). 180 
The marked hypocalcaemia-induced increase in CL by up to 1472ms (Figure 4A), was only to a minor degre 181 
caused by changes in MDP, DDR100, and Vtakeoff (Figure 4D) as quantified by tdia,100 (up to 203ms, Figure 4B). 182 
The strongest driver of CL increase at low [Ca2+]o was prolonged late DD, i.e. slowed DDR after the first 100ms 183 
(Figure 4C). APD90 changes (up to -8ms) mildly attenuated the hypocalcaemia-induced CL increase.  184 
Changes of [K+]o affected spontaneous beating rate and AP morphology to a smaller degree than [Ca
2+]o changes. 185 
Hyperkalemia led to a mild decrease of CL up to -225ms at 8.8mM compared to 5.4mM (Figure 5A). The 186 
tachycardic effect of hyperkalemia was mainly caused by faster late DD (Figure 5C) and to a lesser degree by 187 
early DD (Figure 5B) and APD shortening whereas the tak off potential was unaffected (Figure 5D). 188 
Varying the extracellular sodium concentration had a minor effect on the spontaneous beating of the human 189 
sinus node cell model. Cycle length increased by onl 3.9% when decreasing [Na+]o from 140 to 120mM and 190 
decreased by 3.9% when increasing [Na+]o from 140 to 160mM. Other AP features were hardly affected as well 191 
(maximum changes of 2.6mV for overshoot, 0.18mV for MDP, 7ms for APD90, 2.2mV/ms for DDR100). 192 
 193 
Figure 4: Changes of action potential characteristics upon changes of extracellular calcium concentration [Ca2+]o. (A) cycle 194 
length of spontaneous sinus node cell beating, (B) first order approximation of diastolic depolarization time based on the 195 
first 100ms including effects of MDP, DDR100, and the takeoff potential, (C) diastolic depolarization time change not covered 196 
by the first order approximation tdia,100, (D) action potential takeoff potential. The thick blue line represents the scenario in 197 
which all currents were exposed to the altered [Ca2+]o, whereas the thin lines represent scenarios in which only one current 198 
was exposed to the altered concentration while the other two were computed with 1.8mM. 199 
 200 
Figure 5: Changes of action potential characteristics upon changes of extracellular potassium concentration [K+]o. (A) cycle 201 
length of spontaneous sinus node cell beating, (B) first order approximation of diastolic depolarization time based on the 202 
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first 100ms including effects of MDP, DDR100,and the takeoff potential, (C) diastolic depolarization time change not covered 203 
by the first order approximation tdia,100, (D) action potential takeoff potential.  204 
Attenuated Late Diastolic ICaL and Secondary Attenuation of INaCa are the Drivers of 205 
Hypocalcaemia-Induced Cycle Length Prolongation 206 
To quantify the net effect of altered [Ca2+]o on DD, we analyzed temporal means of currents for i) the entire DD 207 
(tMDP to ttakeoff), ii) early DD (tMDP to tMDP+100ms), and iii) late DD (tMDP+100ms to ttakeoff) (Figure 6). We observed an 208 
almost linear inverse relation between diastolic total transmembrane current Itot and reduction of [Ca
2+]o (Figure 209 
6Ai), particularly during late DD (Figure 6Aiii). The strongest contributors to this effect were INaCa (Figure 6Bi) 210 
and ICaT (Figure 6Ci) as reduced inward currents, the latter particularly during early DD. Decreased outward 211 
currents IKr and INaK (Figure 6Di) and to a smaller extent ISK (Figure 6Ei) partly counterbalanced the reduced 212 
influx.  213 
By exposing only a single current of the three that are directly affected by changes of [Ca2+]o (ICaL, ICaT, and 214 
INaCa) to the altered extracellular calcium concentration, ICaL could be identified as the primary driver of 215 
hypocalcaemia-induced CL prolongation (red lines in Figure 3 & Figure 4, dashed lines in Figure 6 & Figure 7). 216 
Even if ICaT and INaCa still experienced the reference [Ca
2+]o of 1.8mM, the bradycardic effect of hypocalcaemia 217 
was retained almost completely (prolongation by 1261ms vs. 1472ms at 0.8mM, Figure 4A). The contribution of 218 
ICaT during early DD (Figure 6Aii+Cii) had only a markedly smaller effect on CL (prolongation by 83ms at 219 
0.8mM, Figure 4A).  220 
The mechanism by which ICaL markedly prolonged CL under hypocalcaemic conditions could be identified as 221 
the following: Lower [Ca2+]o sustainably reduced the ICaL driving force (up to twofold) and therefore its 222 
amplitude during late DD where it is active (Figure 6Biii). The smaller calcium influx into the intracellular and 223 
subsarcolemmal space over time led to lower concentrations there (Figure 7C+D) and also in the sarcoplasmic 224 
reticulum compartments (Figure 7E+F). In turn, INaCa became smaller (Figure 6B), which led to a [Na
+] i decrease 225 
(Figure 7B) ending up in a new cyclic steady state. The intracellular potassium concentration was not markedly 226 
affected by changes of [Ca2+]o (Figure 7A). 227 
 228 
Figure 6: Changes of ionic current and flux mean values during diastolic depolarization upon changes of extracellular 229 
calcium concentration [Ca2+]o. (i) mean over entire diastolic depolarization phase, (ii) mean over first 100ms of diastolic 230 
depolarization, (iii) mean over the late depolarization phase (excluding the first 100ms). The solid lines represent the 231 
scenario in which all currents were exposed to the altered [Ca2+]o, whereas the dashed lines represent scenarios in which 232 
only ICaL was exposed to the altered concentration while the other two (ICaT, INaCa) were computed with 1.8mM. 233 
 234 
Figure 7: Changes of ionic concentrations during diastolic depolarization upon changes of extracellular calcium 235 
concentration [Ca2+]o. (i) maximum and minimum concentrations over entire diastolic depolarization phase, (ii) maximum 236 
and minimum concentrations over first 100ms of diastolic depolarization, (iii) maximum and minimum concentrations over 237 
the late depolarization phase (excluding the first 100ms). The solid lines represent the scenario in which all currents were 238 
exposed to the altered [Ca2+]o, whereas the dashed lines represent scenarios in which only ICaL was exposed to the altered 239 
concentration while the other two (ICaT, INaCa) were computed with 1.8mM.  240 
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Hypocalcaemia is Correlated with Lower Heart Rate in vivo 241 
Table 1: Characteristics of the two populations used to study the empirical in vivo correlation between electrolyte 242 
concentrations and heart rate. 243 
  
number of 
individuals 
(observations) 
% male  age (years)  heart rate 
(bpm)  
total serum 
calcium (mM)  
serum 
potassium (mM)  
Dialysis  741 (4391) 59 63.9 ± 15.73 77.91 ± 11.29 2.22 ± 0.15 4.64 ± 0.54 
 
< 50 138 (815) 60 38.63 ± 9.23 84.46 ± 10.05 2.20 ± 0.16 4.75 ± 0.55 
50 - 69 341 (2038) 63 61.02 ± 5.77 78.11 ± 10.65 2.22 ± 0.15 4.67 ± 0.58 
>= 70 262 (1538) 52 78.97± 6.17 74.19 ± 11.12 2.25 ± 0.13 4.53 ± 0.47 
male 436 (2594) 
 
100   62.30 ± 16.01 78.21 ± 11.17 2.21 ± 0.15 4.67 ± 0.55  
female 305 (1797) 
 
0  64.47 ± 15.24 77.48 ± 11.46 2.25 ± 0.14 4.59 ± 0.54 
NHANES 18141 49 43.01 ± 20.57 73.34 ± 11.96 2.36 ± 0.09 3.97 ± 0.34 
< 50 10918 49 28.70 ± 11.39 74.78 ± 11.79 2.36 ± 0.09 3.94 ± 0.31 
50 to 69 4917 49 59.21 ± 5.64 71.86 ± 11.94 2.35 ± 0.09 3.99 ± 0.38 
>= 70 2306 49 76.20 ± 3.73 69.62 ± 11.61 2.35 ±0.10 4.10 ± 0.41 
male 8915 100  42.79 ± 20.73 71.75 ± 12.00 2.36 ± 0.09 4.03 ± 0.34 
female 9226 0  43.22 ± 20.40 74.87 ± 11.71 2.35 ± 0.09 3.92 ± 0.34 
 244 
As an initial validation step, we studied the empirical in vivo correlation between blood electrolyte 245 
concentrations and heart rate in two large independent populations (baseline characteristics given in Table 1). 246 
Compared to the in silico single cell experiments, one would expect marked attenuation of the hypocalcaemic 247 
effect by an intact autonomic nervous system comprising a control loop for heart rate. Indeed, we found 248 
statistically highly significant evidence of an inverse relation between total serum Ca and heart rate (Figure 8) in 249 
both populations. In HD patients, the effect became more pronounced with age with no significant correlation for 250 
patients younger than 50 years, 5.35±1.83bpm/mM total Ca for 50-70 years (p<0.005), and 6.32±2.29bpm/mM 251 
total Ca for individuals of age >70 years (p<0.01). This age dependency was not seen in the NHANES 252 
individuals, which overall had a good renal clearance (eGFR (17) 102.1±28.5ml/min/1.73m2; <15ml/min/1.73m2 253 
in only 0.29% of individuals). The strength of the linear dependency of total serum calcium and heart rate was 254 
more pronounced in the NHANES data across age groups: <50 years (9.63±1.30bpm/mM total Ca, p<0.001), 50-255 
70 years (8.75±1.99bpm/mM total Ca, p<0.001), and >70 years (9.94±2.42bpm/mM total Ca, p<0.001). 256 
Potassium on the other hand had a similar inverse correlation to heart rate for all age groups in the HD257 
population: <50 years (-2.09±0.66bpm/mM K, p<0.005), 50-70 years (-1.55±0.42bpm/mM K, p<0.001), and >70258 
years (-1.73±0.54 bpm/mM K, p<0.005). The effect was similar in the NHANES individuals with only a lower 259 
significance in the age group 50-70 years.  260 
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The bradycardic effect of hypocalcaemia was markedly stronger in males with a factor of approximately 2 261 
between the results for males and females seen in both the NHANES and HD populations. [K+]o had a significant 262 
inverse correlation with HR in both sexes. 263 
 264 
Figure 8: Forest plot of linear dependency between total serum calcium (blue) and potassium (red) concentrations and in 265 
vivo heart rate. Data from a linear mixed effects model of 741 hemodialysis patients (4391 observations) are indicated by 266 
squares, circles represent a linear regression of 18145 individuals from the NHANES cross-sectional study representative of 267 
the US population. 268 
 269 
Figure 9: Histogram of heart rate (A), total serum calcium (B), and serum potassium (C) distributions in the NHANES and 270 
hemodialysis populations.  271 
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Discussion 272 
In this study, we tested the hypothesis that human sinus node cellular spontaneous beating rate is affected by 273 
changes in extracellular ion concentrations as occurring in ESRD patients undergoing HD. Using a 274 
computational model, we show that hypocalcaemia has a pronounced bradycardic effect in isolated human sinus 275 
node cells with healthy electrophysiology. The beating rate was reduced by 46bpm when reducing extracellular 276 
ionized calcium concentration [Ca2+]o by 1mM from the in vitro (and in silico) reference value of 1.8mM. The 277 
beating rate sensitivity to changes in [K+]o (hypokalemia) was 4.1x smaller than that due to changes in [Ca
2+]o 278 
(hypocalcaemia). Moreover, as beating rate acceleration was observed for hyperkalemia, [K+]o changes are 279 
unlikely to contribute to the high risk of severe bradycardia towards the end of the interdialytic period during 280 
which potassium is accumulated rather than depleted in HD patients.  281 
By leveraging the advantages of a computational approach, we could dissect the following mechanism 282 
underlying the pronounced bradycardic effect of reduced [Ca2+]o: primarily ICaL is attenuated because of reduced 283 
driving force particularly during late depolarization, which causes a secondary reduction of calcium 284 
concentration in the intracellular compartments andsubsequent attenuation of INaCa also being a diastolic inward 285 
current, thus causing further slowing of DD. The net bradycardic effect is the result of a delicate balance of 286 
inward and outward currents during DD and changes th reof. While the DD integral of individual currents 287 
showed changes of up to 10nA*ms upon changes of [Ca2+]o, they were partly counterbalanced by other changes 288 
yielding a net effect on the DD integral of only 1.2nA*ms. The slowing of spontaneous beating induced by 289 
hypocalcaemia was predominantly due to changes of late DD: only 14% of the CL increase observed at the 290 
lowest [Ca2+]o could be attributed to changes of MDP, DDR100 and Vtakeoff. The fact that 83% of this CL increase 291 
were retained when only ICaL was affected by the change of [Ca
2+]o highlights the key role of late diastolic ICaL in 292 
hypocalcaemia-induced slowing of sinus node pacemaking. 293 
While we further constrained the human sinus node cell model by posing the physiological constraint of 294 
homeostasis, there still is a degree of uncertainty due to sparse experimental data. Therefore, experimental 295 
validation of our in silico derived hypothesis is desirable. However, such experiments would need to be 296 
performed using human sinus node cells because of crucial inter-species differences in the response of sinus 297 
node cells to changes of [Ca2+]o (11). We could show that rabbit experimental data matches well with rabbit 298 
model predictions of the effect of hypocalcaemia both qualitatively and quantitatively but the effect is less 299 
pronounced by a factor of ≈10 compared to human sinus node cells (11). Considering that the bradycardic effect 300 
of hypocalcaemia observed here was mainly due to changes in late DD (beyond 100ms), the inter-species 301 
differences are little surprising given that this phase is not present in species with high baseline heart rate as 302 
typical for common laboratory animals. The effect on early depolarization was comparable across species (11). 303 
Therefore, we decided to substantiate and complement our in silico findings by studying the empirical 304 
correlation between heart rate and serum total calcium in two large populations. We found statistically highly 305 
significant correlations in both the HD as well as the NHANES populations in qualitative agreement with the 306 
model predictions for calcium but not potassium. The mismatch for potassium might indicate that the square root 307 
formulation underestimates the degree of modulation of gKr by [K
+]o and could imply that hyperkalemic 308 
conditions as typical for the later interdialytic period exacerbate the bradycardic effect of hypocalcaemia. The 309 
bradycardic effect of hypocalcaemia was increasingly stronger with higher age for the HD population, which 310 
could be an indication of a gradual loss of function of the autonomic control of heart rate with age in this 311 
population experiencing chronic sympathetic over-activity driven by afferent sensory renal nerves stimulated by 312 
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renal injury (4, 18). Surprisingly, the effect was stronger in the healthier NHANES population than in the HD 313 
population. A potential reason could be the smaller magnitude of calcium excursion and therefore also heart rate 314 
in the healthier NHANES population (Figure 9), which might not cause immediate counteraction by the 315 
autonomic nervous system. To quantitatively relate these in vivo results with the cellular in silico results, the 316 
relation between [Ca2+]o and total serum calcium is important. The distribution of free cations in the vascular, i.e. 317 
serum, and interstitial, i.e. extracellular, compartments has been reported to agree with Donnan theory predicting 318 
a ratio of 0.98 (19). Moreover, around 45% of the total serum calcium is free ionized calcium whereas the rest is 319 
complexed or bound. Taken together, this yields a factor of ≈2.27. Thus, the overall linear effect in the 320 
NHANES population of 9.9bpm/mM total calcium relates to an effect of ≈21.56bpm/mM [Ca2+]o. This in vivo 321 
effect is about half as strong as the observed in silico effect, whose linear regression would likely be smaller than 322 
the factual value of 46bpm/mM [Ca2+]o assuming sampling of the super-linear course center d around the 323 
reference value. However, it may not be forgotten that he empirical data were acquired in vivo, i.e. in a setting 324 
where the heart rate is tightly controlled through various feedback loops via the autonomic nervous system, 325 
which should to a high degree compensate changes of basal cellular beating rate caused by changes of [Ca2+]o. 326 
Considering this, it rather seems surprising that te in vivo effect is not even smaller. 327 
Our study presents a potential mechanism contributing to SCD in ESRD patients: While in a subject with normal 328 
renal function calcium concentrations are generally stable, the course of calcium during the interdialytic period is 329 
highly variable and HD patients may experience relevant changes in serum calcium levels during the dialysis 330 
session. In particular, significant intradialytic reductions in calcium levels can occur if low calcium dialysis 331 
baths (e.g. 1.25mM) are used. Dialysates with low Ca2+ concentrations are also associated with a higher risk of 332 
intra-dialysis sudden cardiac arrest (20). The patients developing hypocalcemia over the course of the 333 
interdialytic days will experience a lower basal sinus node beating rate, which will normally be counterbalanced 334 
by an increase in sympathetic tone. However, a sudden loss of sympathetic tone as systematically observed in 335 
mouse models of ESRD (21) will unmask the lower basal sinus node beating rate, similar to those resulting from 336 
simulations not taking into account autonomic contrl, and cause extreme bradycardia and eventually asystole 337 
within seconds to minutes as reported for bradycardi  sudden death in HD patients (22) if secondary pacemakers 338 
cannot take over. 339 
This hypothesis is in line with a recent epidemiological study comprising 28,471 dialysis patients (23) showing 340 
that ESRD patients on HD have an almost 6x increased incidence of requiring pacemaker insertion compared to 341 
matched patients with normal kidney function. Of note, all of the 4 patients suffering SCD in the study by Sacher 342 
et al. (22) had a preserved ejection fraction, suggesting that the fatal arrhythmia was not due to an underlying 343 
severe heart disease. Moreover, all of them had a record of diabetes mellitus, which is associated with autonomic 344 
neuropathy, compared to only 55% of those patients alive at the end of the follow-up period. If the cru ial role of 345 
hypocalcaemia is confirmed, continuous non-invasive remote monitoring of the blood calcium level using ECG-346 
derived features (24, 25) could help to reduce the SCD incidence. In addition, one could envision to explore 347 
ways to pharmacologically modulate ICaL in order to reduce dependence on [Ca
2+]o, thus yielding a more robust 348 
pacemaking behavior over a wider range of extracellular calcium concentrations including hypocalcaemic 349 
conditions. In this context, the role of calcium channel blockers that are widely used in ESRD patients a d affect 350 
myocytes as well as blood vessels should be investigated in light of our hypothesis. In particular, the non‐351 
dihydropyridine type blockers that bind preferentially to L type channels in the cardiac muscles appear 352 
interesting and a negative chronotropic effect in line with our findings has been reported (26). 353 
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Limitations 354 
Several limitations pertain to this study: i) The in silico reference concentrations reflect standard in vitro 355 
conditions but not physiological in vivo concentrations. In particular, ionized calcium has been reported to vary 356 
in the range 0.9 to 1.6 mM in HD patients (27). The historical reasons and potential implications of this 357 
mismatch for calcium were discussed by Severi et al. (28). For the study presented here, one should refrain from 358 
taking absolute calcium concentrations into consideration and rather interpret the results in terms of 359 
concentration changes. Interestingly, the sensitivity of beating rate to calcium changes (slope of the curve in 360 
Figure 4A) becomes steeper in a physiological or para- hysiological range ([Ca2+]o <1.5mM), and even more in 361 
conditions of pronounced hypocalcaemia. ii) The uremic milieu in HD patients has been shown to affect cellular 362 
electrophysiology as reviewed in (7). These changes have not been taken into consideration here as it is not clear 363 
how they pertain to sinus node cardiomyocytes. Also, we did not consider changes of ion channel properties due 364 
to changes of surface charge related to varying [Ca2+]o (29, 30). iii) Spontaneous cellular pacemaking is a 365 
necessary but not sufficient condition for the initiat on of a heartbeat. In addition, the ensemble of sinus node 366 
cells needs to drive the surrounding working myocardium, which captures the excitation. This aspect will be 367 
considered in future work based on a preliminary study (31). iv) The role of the autonomic nervous system has 368 
not been considered. While the Fabbri et al. model features sympathetic stimulation, it is only available as a 369 
binary on/off switch and beyond the scope of this study. Future work will extend the model to allow for a 370 
gradual sympathetic response allowing to assess howintact autonomic control could compensate for 371 
hypocalcaemia-induced lower basal beating rate. v) This study is based on the Fabbri et al. model of ahuman 372 
sinus node cell (10). Inherent sinus node heterogeneity and variability has not been considered here and is 373 
currently limited by the amount of available experimental recordings. Nevertheless, a population of models 374 
approach (32) appears desirable for the future. vi) Sympathetic hyperactivity is a frequent phenomenon i  ESRD 375 
patients (18) and future studies should extend the s atistical analysis to co-morbidities that are associated with 376 
autonomic neuropathy to consider these potential additional confounding factors beyond age. 377 
Conclusion 378 
We derived an experimentally testable hypothesis of a pathomechanism underlying the high rate of sudden 379 
bradycardic deaths in HD patients. Our computational study suggests that a reduction of extracellular calcium 380 
concentration slows down cellular sinus node pacemaking severely by attenuation of ICaL and secondary of INaCa 381 
during late DD. While normally compensated by a higher sympathetic tone, a sudden loss of sympathetic tone 382 
could unmask the low basal sinus node beating rate under hypocalcaemic conditions and cause extreme 383 
bradycardia. The combination of these two mechanisms (sudden loss of sympathetic tone under hypocalcaemi  384 
conditions) could cause bradycardic SCD and contribute to the high prevalence of SCD in HD patients. The 385 
mechanistic in silico study is complemented with an in vivo analysis comprising >20,000 observations, which 386 
supports the computational findings. Our results could be a crucial first step to elucidate the pathomechanism 387 
behind the unexplained high rate of SCD in HD patients and help to reduce its incidence eventually. 388 
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Model schematic
Starting point: rabbit SAN cell model by Severi et al. 2012 (the most recent and updated
published SAN cell model).
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